This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbruck-Centrum Fur Molekularc Medizin. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Diego Walther - Innovator in Neuronal Disease Treatment
Introduction
Diego Walther is a prominent inventor based in Berlin, Germany, known for his groundbreaking work in the field of pharmaceuticals. With a focus on diagnosing neuronal diseases and addressing primary hemostasis deficiency, his contributions are making significant strides in medical science.
Latest Patents
Diego Walther holds a patent for a method aimed at diagnosing neuronal diseases and treating primary hemostasis deficiency. The patent details pharmaceutical compositions designed for the treatment of primary hemostasis deficiency, methods for diagnosing neuronal disorders, and approaches for suppressing the immune system. He discloses isoforms that are crucial for maintaining primary hemostasis, T-cell mediated immune responses, neuron-specific tryptophan hydroxylase (TPH), and neuronal tryptophan hydroxylase.
Career Highlights
Walther is associated with the Max Delbrück Center for Molecular Medicine, where he applies his expertise to advance medical research. His position at this prestigious institution reflects his commitment to enhancing our understanding of neuronal diseases and their treatments.
Collaborations
Throughout his career, Diego Walther has worked closely with Michael Bader, a notable figure in his research endeavors. Their collaboration has fostered innovative approaches and contributed to the development of effective medical treatments.
Conclusion
Diego Walther’s innovative work and patent contributions in the realm of neuronal diseases and hemostasis deficiency demonstrate his dedication to advancing medical science. His work continues to hold promise for improved diagnostic and therapeutic methods, making a significant impact in the healthcare field.